274 related articles for article (PubMed ID: 12721767)
1. Inhibition of early 99mTc-MIBI uptake by Bcl-2 anti-apoptotic protein overexpression in untreated breast carcinoma.
Del Vecchio S; Zannetti A; Aloj L; Caracò C; Ciarmiello A; Salvatore M
Eur J Nucl Med Mol Imaging; 2003 Jun; 30(6):879-87. PubMed ID: 12721767
[TBL] [Abstract][Full Text] [Related]
2. Bcl-2 overexpression prevents 99mTc-MIBI uptake in breast cancer cell lines.
Aloj L; Zannetti A; Caracó C; Del Vecchio S; Salvatore M
Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):521-7. PubMed ID: 14666386
[TBL] [Abstract][Full Text] [Related]
3. Dynamic coupling of 99mTc-MIBI efflux and apoptotic pathway activation in untreated breast cancer patients.
Del Vecchio S; Zannetti A; Ciarmiello A; Aloj L; Caracò C; Fonti R; Botti G; D'Aiuto G; Salvatore M
Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):809-14. PubMed ID: 12029556
[TBL] [Abstract][Full Text] [Related]
4. Correlation between 99mTc-MIBI uptake and angiogenesis in MIBI-positive breast lesions.
Bekiş R; Degirmenci B; Aydin A; Ozdogan O; Canda T; Durak H
Nucl Med Biol; 2005 Jul; 32(5):465-72. PubMed ID: 15982577
[TBL] [Abstract][Full Text] [Related]
5. 99mTc-MIBI scintigraphy as a functional method for the evaluation of multidrug resistance in breast cancer patients.
Sergieva SB; Timcheva KV; Hadjiolov ND
J BUON; 2006; 11(1):61-8. PubMed ID: 17318954
[TBL] [Abstract][Full Text] [Related]
6. Assessment of 99mTc-MIBI SPECT(/CT) to monitor multidrug resistance-related proteins and apoptosis-related proteins in patients with ovarian cancer: a preliminary study.
Kurata S; Ushijima K; Kawahara A; Kaida H; Kawano K; Hirose Y; Kage M; Kamura T; Ishibashi M; Abe T
Ann Nucl Med; 2015 Aug; 29(7):643-9. PubMed ID: 25921216
[TBL] [Abstract][Full Text] [Related]
7. Correlation between uptake of Tc-99m sestaMIBI and prognostic factors of breast cancer.
Cwikla JB; Buscombe JR; Kolasinska AD; Parbhoo SP; Thakrar DS; Hilson AJ
Anticancer Res; 1999; 19(3B):2299-304. PubMed ID: 10472348
[TBL] [Abstract][Full Text] [Related]
8. Quantified 99mTc-MIBI scintigraphy for predicting chemotherapy response in breast cancer patients: factors that influence the level of 99m Tc-MIBI uptake.
Fuster D; Muñoz M; Pavia J; Palacín A; Bellet N; Mateos JJ; Martín F; Ortega M; Setoain FJ; Pons F
Nucl Med Commun; 2002 Jan; 23(1):31-8. PubMed ID: 11748435
[TBL] [Abstract][Full Text] [Related]
9. Lack of correlation between Tc-99m-sestaMIBI uptake and cadherin expression in infiltrating ductal breast carcinoma as prognostic indicators.
Uğur Y; Sari O; Uğur O; Korkusuz P; Varoğlu E; Arslan N; Gürcan N; Yildirim M; Sökmensüer C; Aşan E; Aras T
Ann Nucl Med; 2003 Jun; 17(4):281-7. PubMed ID: 12932110
[TBL] [Abstract][Full Text] [Related]
10. Role of thallium-201 chloride and Tc-99m methoxy-isobutyl-isonitrite (sestaMIBI) in evaluation of breast masses: correlation with the immunohistochemical characteristic parameters (Ki-67, PCNA, Bcl, and angiogenesis) in malignant lesions.
Omar WS; Eissa S; Moustafa H; Farag H; Ezzat I; Abdel-Dayem HM
Anticancer Res; 1997; 17(3B):1639-44. PubMed ID: 9179210
[TBL] [Abstract][Full Text] [Related]
11. Uptake and washout of 99mTcV-dimercaptosuccinic acid and 99mTc-sestamibi in the assessment of histological type and grade in breast cancer.
Papantoniou V; Christodoulidou J; Papadaki E; Valotassiou V; Souvatzoglou M; Louvrou A; Feida H; Sotiropoulou M; Pampouras G; Michalas S; Zerva C
Nucl Med Commun; 2002 May; 23(5):461-7. PubMed ID: 11973487
[TBL] [Abstract][Full Text] [Related]
12. Uptake of Tc-99m MIBI related to tumour size and type.
Buscombe JR; Cwikla JB; Thakrar DS; Hilson AJ
Anticancer Res; 1997; 17(3B):1693-4. PubMed ID: 9179220
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of chest single photon emission computed tomography with technetium-99m methoxyisobutylisonitrile to predict taxol based chemotherapy response in advanced non-small cell lung cancer.
Shih CM; Hsu WH; Huang WT; Wang JJ; Ho ST; Kao A
Cancer Lett; 2003 Sep; 199(1):99-105. PubMed ID: 12963129
[TBL] [Abstract][Full Text] [Related]
14. Prediction of chemotherapeutic response by Technetium 99m--MIBI scintigraphy in breast carcinoma patients.
Takamura Y; Miyoshi Y; Taguchi T; Noguchi S
Cancer; 2001 Jul; 92(2):232-9. PubMed ID: 11466674
[TBL] [Abstract][Full Text] [Related]
15. 99mTc-MIBI SPET in non-small cell lung cancer in relationship with Pgp and prognosis.
Yüksel M; Cermik TF; Doğanay L; Karlikaya C; Cakir E; Salan A; Berkarda S
Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):876-81. PubMed ID: 12111127
[TBL] [Abstract][Full Text] [Related]
16. Expression of drug resistance protein related to Tc-99m MIBI breast imaging.
Sun SS; Hsieh JF; Tsai SC; Ho YJ; Kao CH
Anticancer Res; 2000; 20(3B):2021-5. PubMed ID: 10928145
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo study of 99mTc-MIBI encapsulated in PEG-liposomes: a promising radiotracer for tumour imaging.
Belhaj-Tayeb H; Briane D; Vergote J; Kothan S; Léger G; Bendada SE; Tofighi M; Tamgac F; Cao A; Moretti JL
Eur J Nucl Med Mol Imaging; 2003 Apr; 30(4):502-9. PubMed ID: 12536243
[TBL] [Abstract][Full Text] [Related]
18. [Correlation between accumulation of (99m)Tc-MIBI in breast cancer or benign lesion, cell proliferation and angiogenesis].
Chen J; Yin Y; Chen S
Zhonghua Wai Ke Za Zhi; 1998 Sep; 36(9):553-5. PubMed ID: 11825464
[TBL] [Abstract][Full Text] [Related]
19. The role of 99mTc-MIBI scintigraphy in the assessment of MDR1 overexpression in patients with musculoskeletal sarcomas: comparison with therapy response.
Burak Z; Ersoy O; Moretti JL; Erinç R; Ozcan Z; Dirlik A; Sabah D; Basdemir G
Eur J Nucl Med; 2001 Sep; 28(9):1341-50. PubMed ID: 11585293
[TBL] [Abstract][Full Text] [Related]
20. 99mTc-MIBI imaging as a predictor of therapy response in osteosarcoma compared with multidrug resistance-associated protein and P-glycoprotein expression.
Burak Z; Moretti JL; Ersoy O; Sanli U; Kantar M; Tamgac F; Basdemir G
J Nucl Med; 2003 Sep; 44(9):1394-401. PubMed ID: 12960182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
